Drug Type Molecular glue |
Synonyms- |
Target |
Action degraders |
Mechanism VAV1 degraders(vav guanine nucleotide exchange factor 1 degraders) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Digestive System Disorders | Discovery | - | 13 Jan 2026 | |
| Immune System Diseases | Discovery | - | 13 Jan 2026 | |
| Intervertebral Disc Degeneration | Discovery | - | 13 Jan 2026 | |
| Other Diseases | Discovery | - | 13 Jan 2026 | |
| Pulmonary Fibrosis | Discovery | - | 13 Jan 2026 | |
| Renal fibrosis | Discovery | - | 13 Jan 2026 | |
| Uveitis | Discovery | - | 13 Jan 2026 |





